Skip to main content
Clinical Trials/NCT01945645
NCT01945645
Completed
N/A

Ready to Act. A Health Education Programme for People With Screen-detected Hyperglycaemia

University of Aarhus1 site in 1 country509 target enrollmentSeptember 2006

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 Diabetes Mellitus
Sponsor
University of Aarhus
Enrollment
509
Locations
1
Primary Endpoint
Modelled cardiovascular disease risk
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

A pre-randomized study in primary health care was designed to investigate health education in a subpopulation extracted from general practitioners (GPs) in one Danish county in the treatment arm of the ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care) study, DK. The overall objective of the 'Ready to Act' health education programme was to support the participants' competences in daily life and act appropriately with respect to their dysglycaemic condition. The achievement of action competence involved four learning objectives: intrinsic motivation, informed decision-making, action experience and social involvement. The programme was delivered in primary care settings (health centre or GP surgeries) by nurses, dieticians, physiotherapists and GPs.

Registry
clinicaltrials.gov
Start Date
September 2006
End Date
December 2010
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age 40-69 years at the time of screening and diagnosed with screen-detected T2D, IGT or IFG (according to WHO criteria).

Exclusion Criteria

  • women who were pregnant or lactating, those with a psychotic illness or an illness with a prognosis of less than one year.

Outcomes

Primary Outcomes

Modelled cardiovascular disease risk

Time Frame: 3 years after intervention, dec 2010

The risk is measured by a SCORE model uses information on age, sex, smoking status, total cholesterol and systolic blood pressure. It provides an estimate of ten-year fatal cardiovascular disease risk

Secondary Outcomes

  • Glycated hemoglobin(3 years after intervention, dec 2010)
  • se-cholesterol(3 years after intervention, dec 2010)
  • Blood pressure(3 years after intervention, dec 2010)
  • Physical activity(3 years after intervention, dec 2010)
  • Smoking(3 years after intervention, 2010)
  • Patient Activation(One year and three year (2006, 2007, 2010))

Study Sites (1)

Loading locations...

Similar Trials